Study to Evaluate Satisfaction and Usability of DuoResp® SPIROMAX® in Asthma and COPD Treatment
NCT02384577
·
clinicaltrials.gov ↗
COMPLETED
Status
4034
Enrollment
INDUSTRY
Sponsor class
Conditions
Patient Satisfaction
Interventions
DRUG:
Budesonide, Formoterol Fumarate Dihydrate
Sponsor
Teva Pharma GmbH